Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus

被引：25

作者：

Cash B.D. ^{[1
]}

Johnston L.R. ^{[2
]}

Johnston M.H. ^{[2
]}

机构：

[1] Department of Gastroenterology, National Naval Medical Center, Bethesda, MD 20889, Wisconsin Avenue

[2] Lancaster Gastroenterology, Inc., Lancaster, PA 17604-3200

来源：

World Journal of Surgical Oncology | / 5卷 / 1期

关键词：

Esophageal Cancer; Lansoprazole; Esophageal Carcinoma; African American Male; Sustained Remission;

D O I：

10.1186/1477-7819-5-34

中图分类号：

学科分类号：

摘要：

Background: Esophageal carcinoma is the ninth most prevalent cancer worldwide with squamous cell carcinoma (SCCA) and adenocarcinoma accounting for the vast majority of new cases (13,900 in 2003). Cure rates in the U.S. are less than 10%, similar to lung cancer. More than 50% of patients with esophageal carcinoma present with unresectable or metastatic disease, are not surgical candidates, or display disease progression despite the addition of neoadjuvant chemoradiotherapy to surgery. Need for improved palliation exits. Case presentation: This case describes a 73-year-old African American male who presented with recurrent squamous cell carcinoma (SCCA) of the esophagus who has a achieved complete remission for 24 months via endoscopic cryospray ablation. Conclusion: Endoscopic cryo spray ablation warrants further investigation as a palliative treatment modality for esophageal cancer. This is the first reported case in the medical literature. © 2007 Cash et al; licensee BioMed Central Ltd.

引用

共 20 条

[11]

Johnston M.H., Cryotherapy and other newer techniques, Gastrointestinal Endosc, 13, pp. 491-504, (2003)

[12]

Johnston M.H., Eastone J.A., Horwhat J.D., Cartledge J., Mathews J.S., Foggy J.R., Cryoablation of Barrett's Esophagus: A pilot study, Gastrointest Endosc, 62, pp. 842-848, (2005)

[13]

Hofstetter W., Swisher G., Correa A.M., Hess K., Putnam J.B., Ajani J.A., Treatment outcomes of resected esophageal cancer, Ann Surg, 236, pp. 376-385, (2002)

[14]

Mariette C., Balon J.M., Piessen G., Fabre S., Van Seuningen I., Triboulet J.P., Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease, Cancer, 97, pp. 1616-1623, (2003)

[15]

Lightdale C.J., Esophageal cancer, Am J Gastroenterol, 94, pp. 20-29, (1999)

[16]

Grana L., Ablin R.J., Goldman S., Milhouse E., Freezing of the esophagus: Histological changes and immunological response, Int Surg, 66, pp. 295-301, (1981)

[17]

Dvorakova K., Payne C.M., Ramsey L., Bernstein H., Holubec H., Chavarria M., Bernstein C., Sampliner R.E., Riley C., Prasad A., Garewal H., Apoptosis resistance in Barrett's esophagus: Ex vivo bioassy of live stressed tissue, Am J Gastroenterol, 100, pp. 424-431, (2005)

[18]

Joosten J.J.A., Muijen G.N.P., Wobbes T.H., Ruers T.J.M., In Vivo Destruction by Cryoablation Can Induce Inhibition of Secondary Tumor Growth: An Experimental Study, Cryobiology, 41, pp. 49-58, (2001)

[19]

Hanai A., Yang W., Ravikumar T.S., Induction of apoptosis in human colon carcinoma cells HT29 by sublethal cryo-injury: Mediation by cytochrome C release, Int J Cancer, 93, pp. 526-533, (2001)

[20]

Clarke D.M., Baust J.M., Buskirk R.G., Baust J.G., Chemo-Cryo Combination Therapy: An Adjunctive Model for the Treatment of Prostate Cancer, Cryobiology, 42, pp. 274-285, (2001)

← 1 2 →